Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates
Therapeutics based on short interfering RNAs (siRNAs) delivered to hepatocytes have been approved, but new delivery solutions are needed to target additional organs. Here we show that conjugation of 2′- O -hexadecyl (C16) to siRNAs enables safe, potent and durable silencing in the central nervous sy...
Saved in:
| Published in: | Nature biotechnology Vol. 40; no. 10; pp. 1500 - 1508 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
New York
Nature Publishing Group US
01.10.2022
Nature Publishing Group |
| Subjects: | |
| ISSN: | 1087-0156, 1546-1696, 1546-1696 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!